2015 ACBS Landline-Cellphone Combined Prevalence Tables
BRFSS Asthma Call-back Survey Prevalence TABLE 7
| State/Territory | Current | Active | ||||||
|---|---|---|---|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | |
| Connecticut | 348 | N/A | N/A | (N/A – N/A) | 381 | N/A | N/A | (N/A – N/A) |
| Florida | 215 | N/A | N/A | (N/A – N/A) | 238 | 6.1 | 1.8 | (2.6 – 9.6) |
| Georgia | 175 | 9.8 | 2.9 | (4.1 – 15.5) | 177 | 10.0 | 3.0 | (4.1 – 15.9) |
| Hawaii | 162 | 21.2 | 5.0 | (11.4 – 31.0) | 192 | 18.0 | 4.2 | (9.8 – 26.2) |
| Indiana | 208 | N/A | N/A | (N/A – N/A) | 223 | N/A | N/A | (N/A – N/A) |
| Iowa | 181 | N/A | N/A | (N/A – N/A) | 194 | N/A | N/A | (N/A – N/A) |
| Kansas | 591 | 7.7 | 1.2 | (5.3 – 10.1) | 614 | 8.4 | 1.3 | (5.9 – 10.9) |
| Maine | 264 | N/A | N/A | (N/A – N/A) | 275 | N/A | N/A | (N/A – N/A) |
| Massachusetts | 252 | N/A | N/A | (N/A – N/A) | 278 | N/A | N/A | (N/A – N/A) |
| Michigan | 410 | 6.0 | 1.4 | (3.3 – 8.7) | 442 | 6.7 | 1.5 | (3.8 – 9.6) |
| Minnesota | 606 | 10.5 | 1.9 | (6.8 – 14.2) | 630 | 10.5 | 1.8 | (7.0 – 14.0) |
| Mississippi | 168 | N/A | N/A | (N/A – N/A) | 173 | N/A | N/A | (N/A – N/A) |
| Missouri | 197 | 10.8 | 2.6 | (5.7 – 15.9) | 205 | 9.4 | 2.4 | (4.7 – 14.1) |
| Montana | 144 | N/A | N/A | (N/A – N/A) | 149 | N/A | N/A | (N/A – N/A) |
| Nebraska | 474 | 5.3 | 1.1 | (3.1 – 7.5) | 507 | 5.5 | 1.2 | (3.1 – 7.9) |
| Nevada | 108 | N/A | N/A | (N/A – N/A) | 114 | N/A | N/A | (N/A – N/A) |
| New Hampshire | 212 | N/A | N/A | (N/A – N/A) | 217 | N/A | N/A | (N/A – N/A) |
| New Jersey | 421 | 6.6 | 1.8 | (3.1 – 10.1) | 448 | 6.4 | 1.7 | (3.1 – 9.7) |
| New Mexico | 262 | N/A | N/A | (N/A – N/A) | 278 | 11.2 | 3.1 | (5.1 – 17.3) |
| New York | 217 | 9.1 | 2.7 | (3.8 – 14.4) | 240 | 9.7 | 2.7 | (4.4 – 15.0) |
| Ohio | 391 | 7.6 | 2.0 | (3.7 – 11.5) | 429 | 6.7 | 1.8 | (3.2 – 10.2) |
| Oregon | 196 | N/A | N/A | (N/A – N/A) | 223 | N/A | N/A | (N/A – N/A) |
| Pennsylvania | 208 | N/A | N/A | (N/A – N/A) | 226 | N/A | N/A | (N/A – N/A) |
| Rhode Island | 204 | N/A | N/A | (N/A – N/A) | 220 | N/A | N/A | (N/A – N/A) |
| Texas | 370 | 7.2 | 1.9 | (3.5 – 10.9) | 426 | 7.1 | 1.8 | (3.6 – 10.6) |
| Utah | 374 | 7.3 | 1.7 | (4.0 – 10.6) | 403 | 7.8 | 1.7 | (4.5 – 11.1) |
| Vermont | 249 | 8.9 | 2.2 | (4.6 – 13.2) | 254 | 10.0 | 2.3 | (5.5 – 14.5) |
| Wisconsin | 282 | N/A | N/A | (N/A – N/A) | 291 | N/A | N/A | (N/A – N/A) |
| Puerto Rico | 294 | 10.2 | 2.2 | (5.9 – 14.5) | 330 | 8.5 | 1.9 | (4.8 – 12.2) |
| 29 states / area | 8,183 | 9.3 | 0.7 | (7.9 – 10.7) | 8,777 | 8.6 | 0.7 | (7.2 – 10.0) |
| Median | 8.3 | 8.5 | ||||||
| Range | 5.3-21.2 | 5.5-18.0 | ||||||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Landline and cell phone combined sample size excludes “DK/Refused”
§ Standard error
† Confidence interval
N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > 0.30
Page last reviewed: February 14, 2017